학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 9건 | 목록
1~20
Academic Journal
Finkle JD; Tempus Labs, Chicago, IL, USA.; Boulos H; Tempus Labs, Chicago, IL, USA.; Driessen TM; Tempus Labs, Chicago, IL, USA.; Lo C; Tempus Labs, Chicago, IL, USA.; Blidner RA; Tempus Labs, Chicago, IL, USA.; Hafez A; Tempus Labs, Chicago, IL, USA.; Khan AA; Tempus Labs, Chicago, IL, USA.; Lozac'hmeur A; Tempus Labs, Chicago, IL, USA.; McKinnon KE; Tempus Labs, Chicago, IL, USA.; Perera J; Tempus Labs, Chicago, IL, USA.; Zhu W; Tempus Labs, Chicago, IL, USA.; Dowlati A; University Hospitals Seidman Cancer Center, Cleveland, OH, USA.; White KP; Tempus Labs, Chicago, IL, USA.; Tell R; Tempus Labs, Chicago, IL, USA. bob@tempus.com.; Beaubier N; Tempus Labs, Chicago, IL, USA. Nike.Beaubier@tempus.com.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Academic Journal
Haynes BC; Asuragen, Inc., Austin, TX, USA. Electronic address: bhaynes@asuragen.com.; Blidner RA; Asuragen, Inc., Austin, TX, USA.; Cardwell RD; Asuragen, Inc., Austin, TX, USA.; Zeigler R; Asuragen, Inc., Austin, TX, USA.; Gokul S; Asuragen, Inc., Austin, TX, USA.; Thibert JR; Asuragen, Inc., Austin, TX, USA.; Chen L; Asuragen, Inc., Austin, TX, USA.; Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Papadimitrakopoulou VA; Department of Thoracic/Head and Neck Medical Oncology, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Latham GJ; Asuragen, Inc., Austin, TX, USA.
Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Academic Journal
Blidner RA; Asuragen, Inc., Austin, Texas.; Haynes BC; Asuragen, Inc., Austin, Texas.; Hyter S; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.; Schmitt S; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.; Pessetto ZY; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.; Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas; University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas.; Su D; Q Squared Solutions Expression Analysis LLC, Morrisville, North Carolina.; Hurban P; Q Squared Solutions Expression Analysis LLC, Morrisville, North Carolina.; van Kempen LC; The Molecular Pathology Centre, Jewish General Hospital, Montreal, Quebec, Canada.; Aguirre ML; The Molecular Pathology Centre, Jewish General Hospital, Montreal, Quebec, Canada.; Gokul S; Asuragen, Inc., Austin, Texas.; Cardwell RD; Asuragen, Inc., Austin, Texas.; Latham GJ; Asuragen, Inc., Austin, Texas. Electronic address: glatham@asuragen.com.
Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE
Academic Journal
Blidner RA; Department of Biological and Agricultural Engineering, Louisiana State University and Agricultural Center, Baton Rouge, LA 70803, USA.; Hammer RP; Lopez MJ; Robinson SO; Monroe WT
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium: Print ISSN: 1747-0277 (Print) Linking ISSN: 17470277 NLM ISO Abbreviation: Chem Biol Drug Des Subsets: MEDLINE
Academic Journal
Casey JP; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, Louisiana 70803, USA.; Blidner RA; Monroe WT
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print Cited Medium: Print ISSN: 1543-8384 (Print) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Academic Journal
Blidner RA; Biological & Agricultural Engineering, Louisiana State University and LSU Agricultural Center, Baton Rouge, LA 70803, USA.; Svoboda KR; Hammer RP; Monroe WT
Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101251620 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1742-206X (Print) Linking ISSN: 17422051 NLM ISO Abbreviation: Mol Biosyst Subsets: MEDLINE
Academic Journal
Downs JC; Department of Biomedical Engineering, Tulane University, New Orleans, LA 70112, USA.; Blidner RA; Bellezza AJ; Thompson HW; Hart RT; Burgoyne CF
Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited Medium: Print ISSN: 0146-0404 (Print) Linking ISSN: 01460404 NLM ISO Abbreviation: Invest Ophthalmol Vis Sci Subsets: MEDLINE
Academic Journal
Bizzaro CL; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Bach CA; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Laboratory of Glycomedicine, Institute of Biology and Experimental Medicine, National Council of Scientific and Technical Investigations, Buenos Aires, Argentina.; Faculty of Exact and Natural Sciences, University of Buenos Aires, Argentina.; Santos RA; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Verrillo CE; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Naranjo NM; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Chaudhari I; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Picone FJ; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Iqbal W; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.; Blidner AG; Laboratory of Glycomedicine, Institute of Biology and Experimental Medicine, National Council of Scientific and Technical Investigations, Buenos Aires, Argentina.; Rabinovich GA; Laboratory of Glycomedicine, Institute of Biology and Experimental Medicine, National Council of Scientific and Technical Investigations, Buenos Aires, Argentina.; Faculty of Exact and Natural Sciences, University of Buenos Aires, Argentina.; Fatatis A; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.; Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Jacobi J; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Goodrich DW; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Zarrabi KK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Kevin Kelly W; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Schiewer MJ; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Academic Journal
Cooksley T; The Christie and Manchester University Foundation Trust, Manchester, UK.; Girotra M; Department of Medicine, Endocrine Division, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.; Ginex P; Oncology Nursing Society, Pittsburgh, PA, USA.; Gordon RA; Clinical Trials, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Anderson R; Department of Immunology, Faculty of Health Sciences, University or Pretoria, Corner Doctor Savage Road and Bophelo Road, Pretoria, 0002, South Africa.; Blidner A; Laboratory of Immunopathology, Institute of Biology and Experimental Medicine-CONICET, Buenos Aires, Argentina.; Choi J; Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Dougan M; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Glezerman I; Renal Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Gupta D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Johnson D; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA.; Shannon VR; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Suarez-Almazor M; Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rapoport BL; Department of Immunology, Faculty of Health Sciences, University or Pretoria, Corner Doctor Savage Road and Bophelo Road, Pretoria, 0002, South Africa. bernardo.rapoport@up.ac.za.; The Medical Oncology Centre of Rosebank, 129 Oxford Road, Saxonwold, 2196, Johannesburg, South Africa. bernardo.rapoport@up.ac.za.
Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Blidner RA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어